Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.)

Digestive and Liver Disease

Volumn 37, Issue 7, 2005, Pages 461-467

  Angelico, M ^a   Gridelli, B ^b   Strazzabosco, M ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^c Bergamo Hospital   (Italy)

Author keywords

End stage liver disease; Liver transplantation; Marginal grafts; Retransplantation; Waiting list mortality; Waiting list priority

Indexed keywords

ACCREDITATION; ADULT; ARTICLE; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; GRAFT RECIPIENT; HEALTH CARE NEED; HEALTH CARE PLANNING; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; ITALY; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; ORGAN DONOR; OUTCOMES RESEARCH; PATHOLOGY; RECURRENT DISEASE; REOPERATION; SURGEON; SURGICAL TRAINING; TREATMENT INDICATION; HOSPITAL ADMISSION; IMMUNOLOGY; ORGANIZATION AND MANAGEMENT; TRANSPLANTATION;

HUMANS; ITALY; LIVER TRANSPLANTATION; LIVING DONORS; REOPERATION; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 26944476332     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.03.006     Document Type: Article

References (25)

1. Burra P., Smedila A., Angelico M., Ascione A., and Rizzetto M. Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.). Dig Liver Dis 32 (2000) 249-256
2. Fagiuoli S., Leandro G., Bellati G., Gasbarrini A., Rapaccini G.L., Pompili M., et al. Liver transplantation in Italy: preliminary 10-year report. The Monotematica AISF-OLT Study Group. Ital J Gastroenterol 28 (1996) 343-350
3. Fagiuoli S., Mirante V.G., Pompili M., Gianni S., Leandro G., Rapaccini G.L., et al., Monotematica AISF 2000-OLT Study Group. Liver transplantation: the Italian experience. Dig Liver Dis 34 (2002) 640-648
4. Trapianto di fegato non urgente dell'adulto. Raccomandazioni della Commissione di studio AISF, Roma; ottobre 2004.
5. Collins B.H., Pirsch J.D., Becker Y.T., Hanaway M.J., Van der Werf W.J., D'Alessandro A.M., et al. Long term results of liver transplantation in older patients 60 years of age and older. Transplantation 70 (2000) 780-783
6. Herrero J.I., Lucena J.F., Quiroga J., Sangro B., Pardo F., Rotellar F., et al. Liver transplantation recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 3 (2003) 1407-1412
7. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
8. Durand F., and Belghiti J. Liver transplantation for hepatocellular carcinoma: should we push the limits?. Liver Transpl 7 (2003) 697-699
9. Roayaie S., Frischer J.S., Emre S.H., Fishbein T.M., Sheiner P.A., Sung M., et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimeters. Ann Surg 235 (2002) 533-539
10. Puoti M., Spinetti A., Ghezzi A., Donato F., Zaltron S., Putzolu V., et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr 24 (2000) 211-217
11. Wali M., Harrison R.F., Gow P.J., and Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 51 (2002) 248-252
12. Zamboni F., Franchello A., David E., Rocca G., Ricchiuti A., Lavezzo B., et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transpl 1 (2001) 53-58
13. Selzner M., and Clavien P.A. Fatty liver in liver transplantation and surgery. Semin Liver Dis 21 (2001) 105-113
14. Yoo H.Y., Molmenti E., and Thuluvath P.J. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 9 (2003) 72-78
15. Vargas H.E., Laskus T., Wang L.F., Lee R., Radkowski M., Dodson F., et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 117 (1999) 149-153
16. Munoz S.J. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl 8 (2002) S82-S87
17. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al., United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003) 91-96
18. Merion R.M. When is a patient too well and when is a patient too sick for liver transplant?. Liver Transpl 10 Suppl. 2 (2004) S69-S73
19. Ghobrial R.M. Retransplantation for recurrent hepatitis C in the model for end-stage liver disease era: How should we or shouldn't we?. Liver Transpl 9 (2003) 1025-1027
20. Tisone G., Angelico M., Palmieri G., Pisani F., Anselmo A., Baiocchi L., et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation 67 (1999) 1308-1313
21. Stegall M.D., Everson G.T., Schroter G., Karrer F., Bilir B., Sternberg T., et al. Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. Hepatology 25 (1997) 173-177
22. Roche B., and Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl 10 Suppl. 2 (2004) S74-S85
23. Chalasani N., Manzarbeitìa C., Ferenci P., Vogel W., Fontana R.J., Voigt M., et al., Pegasys Transplant Study Group. Peginterferon alfa-2a for hepatitis C after liver transplantation. Hepatology 41 (2005) 289-298
24. Karam V., Gunson B., Roggen F., Grande L., Wannoff W., Janssen M., et al., European Liver Transplant Association. Quality control of the ELTR: results of audit visits to the contributing centers. Transplantation 75 (2003) 2167-2173
25. Black N. High-quality clinical databases: breaking down barriers. Lancet 353 (1999) 1205-1206